Viability of cell-laden droplets was performed off-chip to assess the potential applications in 3D encapsulation cell culture and drug discovery assays.
The development of biologically relevant three-dimensional (3D) tissue constructs is essential for the alternative methods of organ transplantation in regenerative medicine, as well as the development of improved drug discovery assays.
These properties establish the potential for using GPCR SMALP in receptor-based drug discovery assays.
This knowledge allowed for the development of animal models and drug discovery assays based on splicing modification and the levels of SMN.
There will be instances, such as drug discovery assays, when it will be desirable to preserve the more physiological annular lipid composition provided by a mammalian cell membrane.
With its ability to decrease the daunting complexity of plasma [ 10] to make it more amenable to protein profiling, SELDI-TOF analysis was once a highly touted technique for plasma proteomic studies, particularly for biomarker discovery assays.
albicans antifungal discovery assay; 1) if the compound has limited solubility in water, 2) if the assayed compound has antifungal activity, as well as nematicidal activity, and 3) if the compound has activity against most fungi, although the fungus used in the screen (C. albicans) maybe unaffected by the compound.
Synovial fluid cytokines and adipokines were quantified using a Rat 27 Multiplex Discovery Assay with Luminex® xMAP technology (eotaxin, EGF, fractalkine, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 p70), IL-12 p70-17A, IL-13, IL-17ACXCL10, GRO/KC, IL-18, TNF-α, G-CSF, GM-CSF, MCP-1, leptin, LIX, MIP-1α, MIP-10/CXCL10, VEGF; Eve Technologies).
Serum cytokines and adipokines were quantified using a Rat 27 Multiplex Discovery Assay with Luminex® xMAP technology (eotaxin, EGF, fractalkine, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 p70), IL-12 p70-17A, IL-13, IL-17ACXCL10, GRO/KC, IL-18, TNF-α, G-CSF, GM-CSF, MCP-1, leptin, LIX, MIP-1α, MIP-10/CXCL10, VEGF; Eve Technologies, Calgary, AB, Canada).
The content of the discovery assay is flexible and highly scalable, permitting the addition of content as the target menu grows.
Endoh et al showed that reverse transcription with 96 hexamers that can not anneal to rRNA, decreases the amount of background amplification and enhances the sensitivity of a virus discovery assay.
